Acupuncture for Premature Ovarian Insufficiency: A Randomized, Non-Inferiority Protocol with Exploratory Epigenetics Analysis.

Premature ovarian insufficiency (POI) occurs when a woman's ovaries stop functioning normally before age 40, leading to fertility challenges and other health concerns. Currently, hormone replacement therapy (HRT) is the standard treatment, but it doesn't always fully restore ovarian function and may cause side effects. Researchers are now investigating whether acupuncture could be just as effective as HRT for women with POI who are trying to conceive through assisted reproductive technology. This study will enroll 572 women with POI and randomly assign them to receive either a standardized acupuncture treatment protocol or HRT according to current medical guidelines. An additional 286 women with normal ovarian function will serve as a comparison group. The researchers will track pregnancy rates as their main measure of success, while also monitoring hormone levels, ovarian reserve markers, pregnancy outcomes, and menopausal symptoms. Uniquely, this study will also examine DNA methylation patterns in ovarian cells to understand how acupuncture might work at a molecular level. This research is particularly important because it could provide strong evidence that acupuncture offers a viable alternative to HRT for women with POI, potentially with fewer side effects. The epigenetic analysis may reveal exactly how acupuncture influences ovarian function, moving beyond traditional explanations. However, it's important to note that this is a protocol paper describing a planned study, so results are not yet available. If you're considering acupuncture for fertility concerns, consult with a licensed acupuncturist who has experience treating reproductive health conditions.

This randomized controlled non-inferiority trial aims to compare acupuncture versus HRT in 572 women with POI undergoing ART, with clinical pregnancy rate as the primary endpoint. The study employs a standardized acupuncture protocol against HRT delivered per 2024 ESHRE guidelines, with an additional 286 normal ovarian function controls for epigenetic comparison. Secondary outcomes include serum sex hormones (FSH, LH, E2, AMH), ovarian reserve markers, ovulation induction parameters, pregnancy outcomes, and Modified Kupperman Index scores. A notable methodological strength is the inclusion of whole-genome bisulfite sequencing (WGBS) of ovarian granulosa cells to explore DNA methylation as a potential mechanism of action. The non-inferiority design suggests the hypothesis that acupuncture may achieve comparable clinical pregnancy rates to standard HRT. This protocol represents a significant advancement in fertility acupuncture research, combining rigorous clinical trial methodology with molecular mechanism investigation. Results may provide evidence-based guidance for integrating acupuncture into POI management protocols, particularly for patients seeking alternatives to HRT or experiencing suboptimal HRT response.